EML share price pummelled: Here's why this expert sees 100% upside

Shares in the payments company have been severely hurt in 2022 but one broker is very optimistic.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The EML share price has been savaged in 2022
  • However, brokers suggest the business’ shares could pull off a big recovery over the next 12 months
  • Ord Minnett’s price target on EML is $2.95

The EML Payments Ltd (ASX: EML) share price has been heavily punished in 2022. It's down by a hefty 55% since the start of the year.

In the last month alone, it has plunged more than 48% and, over the past year, is 73% lower.

But some brokers think that the EML share price can bounce back in a big way. One of those brokers is Ord Minnett.

The company's latest selldown happened after EML's quarterly update for the three months to 31 March 2022. It wasn't as good as Ord Minnett had been hoping.

A man in a business suit holds his coffee cup aloft as he throws his head back and laughs heartily.

Image source: Getty Images

Quarterly recap

Looking at the numbers, EML reported that its quarterly gross debit volume (GDV) was $23.9 billion, up 408%.

Revenue was up 21% to $59.8 million, with gross profit increasing 17% to $42.2 million. However, underlying overheads jumped 50% to $28.6 million.

Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) fell 14% to $13.6 million and underlying net profit after tax and amortisation (NPATA) fell 22% to $8.1 million. Profitability can have an impact on the EML share price.

EML explained that the gross profit margin was impacted predominately by higher negative interest and lower establishment fees in Europe. It said that changes to its treasury investment policy will begin to offset these costs in the fourth quarter.

The overheads rose because of an increased headcount in Europe, increased IT expenditure and the inclusion of the acquired business Sentenial (which accounted for 25% of the increase).

After this quarterly update, the company reduced its FY22 guidance. It said that operational execution issues in Europe and a more risk-averse approach impacted the launch of new programs. It's expecting continued challenges in the fourth quarter which have led to a reduction in the guidance range.

New FY22 guidance

In FY21, EML generated underlying EBITDA of $53.5 million. The previous guidance range was between $58 million to $65 million. The new guidance is for a range of between $52 million to $55 million.

EML generated $32.4 million of underlying NPATA in FY21. In FY22, it was previously expecting to make between $27 million to $34 million of NPATA. Now underlying NPATA is expected to be between $27 million to $30 million. That's a reduction of the mid-point of the guidance.

Ord Minnett on the EML Payments share price

The broker has a buy rating on the business, with a price target of $2.95. That suggests a possible rise of more than 100% in the next 12 months. But who knows what's going to happen next?

Ord Minnett points to a number of things that aren't helping the business right now, however, its valuation looks attractive. It also notes that EML operates in a growing industry and it has the potential to do well.

Based on current projections from the broker, the company is expected to make a net profit in FY23 and the EML share price is valued at 32 times FY23's estimated earnings.

JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended EML Payments. The Motley Fool Australia has positions in and has recommended EML Payments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »